Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
$1.06
+6.0%
$1.31
$3.01
$13.40
$4.28M-0.0822,330 shs325,374 shs
Femasys Inc. stock logo
FEMY
Femasys
$0.88
-0.7%
$0.94
$0.69
$1.80
$28.48M-2.56265,665 shs43,167 shs
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$1.27
+5.8%
$1.13
$0.59
$4.49
$21.82M3.7571,112 shs112,947 shs
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
$1.98
-4.8%
$1.12
$0.35
$0.84
$53.73M-0.2182,237 shs13,782 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
0.00%-10.17%-31.17%-20.30%-90.19%
Femasys Inc. stock logo
FEMY
Femasys
+0.23%-6.16%+3.76%-27.70%-19.08%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
+10.09%+16.50%+15.38%-31.03%-3.23%
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
0.00%+7.22%+147.62%+212.78%+235.48%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Femasys Inc. stock logo
FEMY
Femasys
2.472 of 5 stars
3.53.00.00.00.62.50.6
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
2.2662 of 5 stars
3.55.00.00.00.01.70.0
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
0.00
N/AN/AN/A
Femasys Inc. stock logo
FEMY
Femasys
3.00
Buy$8.67890.02% Upside
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
3.00
Buy$5.00293.70% Upside
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest BLAC, FEMY, QTI, and NXL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/25/2025
Femasys Inc. stock logo
FEMY
Femasys
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00
6/11/2025
Femasys Inc. stock logo
FEMY
Femasys
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$12.00
5/13/2025
Femasys Inc. stock logo
FEMY
Femasys
Jones Trading
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$10.00 ➝ $6.00
5/9/2025
Femasys Inc. stock logo
FEMY
Femasys
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $12.00
(Data available from 7/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/AN/AN/AN/AN/A
Femasys Inc. stock logo
FEMY
Femasys
$1.63M17.47N/AN/A$0.10 per share8.75
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
$170K128.34N/AN/A$0.28 per share4.54
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
$4.00M13.44N/AN/A($1.91) per share-1.04
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Femasys Inc. stock logo
FEMY
Femasys
-$18.82M-$0.91N/AN/AN/A-1,242.06%-392.45%-137.15%8/14/2025 (Estimated)
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$7.61M-$0.83N/AN/A-6,529.77%-277.92%-245.37%8/14/2025 (Estimated)
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
-$4.03MN/A0.00N/AN/AN/A-65.94%8/6/2025 (Estimated)

Latest BLAC, FEMY, QTI, and NXL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025N/A
Femasys Inc. stock logo
FEMY
Femasys
-$0.18N/AN/AN/AN/AN/A
5/13/2025Q1 2025
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
-$0.10-$0.15-$0.05-$0.15$0.04 million$0.04 million
5/8/2025Q1 2025
Femasys Inc. stock logo
FEMY
Femasys
-$0.17-$0.23-$0.06-$0.23$1.14 million$0.34 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/AN/AN/AN/A
Femasys Inc. stock logo
FEMY
Femasys
N/AN/AN/AN/AN/A
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/AN/AN/AN/AN/A
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/AN/AN/A
Femasys Inc. stock logo
FEMY
Femasys
0.02
0.93
0.54
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
N/A
4.56
4.25
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
N/A
1.06
0.48

Institutional Ownership

CompanyInstitutional Ownership
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
55.30%
Femasys Inc. stock logo
FEMY
Femasys
65.27%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
0.65%
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
24.19%

Insider Ownership

CompanyInsider Ownership
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
33.67%
Femasys Inc. stock logo
FEMY
Femasys
11.54%
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
25.26%
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
75.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bellevue Life Sciences Acquisition Corp. stock logo
BLAC
Bellevue Life Sciences Acquisition
N/A4.04 million2.68 millionNot Optionable
Femasys Inc. stock logo
FEMY
Femasys
3032.53 million28.77 millionNot Optionable
Nexalin Technology, Inc. stock logo
NXL
Nexalin Technology
317.18 million12.84 millionNot Optionable
QT Imaging Holdings, Inc. stock logo
QTI
QT Imaging
N/A27.13 million6.68 millionN/A

Recent News About These Companies

QT Imaging (NASDAQ:QTI) Shares Up 1% - What's Next?
QT Imaging Approves Executive Stock Options Plan

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bellevue Life Sciences Acquisition stock logo

Bellevue Life Sciences Acquisition NASDAQ:BLAC

$1.06 +0.06 (+6.00%)
As of 07/18/2025

Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

Femasys stock logo

Femasys NASDAQ:FEMY

$0.88 -0.01 (-0.75%)
Closing price 04:00 PM Eastern
Extended Trading
$0.88 +0.00 (+0.41%)
As of 05:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Nexalin Technology stock logo

Nexalin Technology NASDAQ:NXL

$1.27 +0.07 (+5.83%)
Closing price 04:00 PM Eastern
Extended Trading
$1.27 0.00 (0.00%)
As of 05:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

QT Imaging stock logo

QT Imaging NASDAQ:QTI

$1.98 -0.10 (-4.81%)
As of 07/21/2025

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.